Annual report pursuant to Section 13 and 15(d)

Stock Plans (Tables)

v3.8.0.1
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of Fair Value Assumptions

The assumptions used in calculating the fair values of options granted during the years ended December 31, 2017 and 2016 are set forth in the table below:

 

    

Year Ended

December 31,

2017

  

Year Ended

December 31,

2016

Expected terms (in years)

   5.83 - 6.31    5.58 - 6.08

Expected volatility

   52% -65%    55%% - 60%

Risk-free interest rate

   1.79% - 2.20%    1.30% - 1.72%

Expected dividend yield

   —      —  
Schedule of Stock-based Compensation Expense

The stock-based compensation expense by type of award and by operating expense grouping are presented below:

 

     Year Ended
December 31,
 
     2017      2016  

Stock-based compensation expense by type of award:

     

Restricted stock

   $ 891      $ 151  

Common stock awards

     375        1,442  

Restricted stock units

     327        —    

Stock options

     14,391        137  

Employee stock purchase plan

     105        —    
  

 

 

    

 

 

 

Total

   $ 16,089      $ 1,730  
  

 

 

    

 

 

 

Stock-based compensation expense by operating expense grouping:

     

Sales and marketing

   $ 438      $ 71  

Research and development

     464        31  

General and administrative

     15,187        1,628  
  

 

 

    

 

 

 

Total

   $ 16,089      $ 1,730  
  

 

 

    

 

 

 
Schedule of Restricted Stock Activity

The Company’s restricted stock activity for the year ended December 31, 2017 was as follows:

 

     Shares      Weighted
Average Grant
Date Fair Value
 
Unvested at December 31, 2016      208,886      $ 4.80  
Granted      64,240      $ 15.47  
Forfeited      (22,241)      $ 8.42  
Vested      (103,429)      $ 8.50  
  

 

 

    
Unvested at December 31, 2017      147,456      $ 6.30  
  

 

 

    
Schedule of Stock Option Activity

The Company’s stock option activity for the year ended December 31, 2017 was as follows:

 

     No. of
Options
     Weighted
Average

Exercise
Price
     Weighted
Average
Remaining
Contractual
Term
(Years)
     Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2016

     680,434      $ 2.27        8.49    $ 3,031  

Options Granted

     4,383,208      $ 15.27        

Options Exercised

     (80,829    $ 1.62        

Options Forfeited

     (161,346    $ 9.90        

Options Expired

     (18,873    $ 1.50        
  

 

 

          
Outstanding at December 31, 2017      4,802,594      $ 13.89        9.17      $44,712  
  

 

 

          
Exercisable at December 31, 2017      1,805,482      $ 12.44        8.85      $19,433  
  

 

 

          
Vested and expected to vest at December 31, 2017      4,715,202      $ 13.87        9.17      $43,994  
  

 

 

          
Employee Stock Purchase Plan [Member]  
Schedule of Fair Value Assumptions

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the year ended December 31, 2017 are set forth in the table below:

 

    

Year Ended

December 31,

2017

Expected term (in years)

   0.50

Expected volatility

   53%

Risk-free interest rate

   1.15%

Expected dividend yield

   —  
Restricted Stock Units [Member]  
Schedule of Restricted Stock Activity

The Company’s restricted stock units activity for the year ended December 31, 2017 was as follows:

 

     Shares    Weighted
Average Grant
Date Fair Value
 
Unvested at December 31, 2016    —      $ —    
Granted    35,576    $ 14.76  
Forfeited    —      $ —    
Vested    —      $ —    
  

 

  
Unvested at December 31, 2017    35,576    $ 14.76